Accessibility Menu
 
Avicanna logo

Avicanna

(OTC) AVCNF

Current Price$0.12
Market Cap$14.32M
Since IPO (2019)-96%
5 Year-88%
1 Year-54%
1 Month-14%

Avicanna Financials at a Glance

Market Cap

$14.32M

Revenue (TTM)

$25.50M

Net Income (TTM)

$1.88M

EPS (TTM)

$-0.01

P/E Ratio

-9.57

Dividend

$0.00

Beta (Volatility)

0.63 (Low)

Price

$0.12

Volume

33,375

Open

$0.12

Previous Close

$0.12

Daily Range

$0.12 - $0.13

52-Week Range

$0.11 - $0.26

AVCNF News

No articles available.

AVCNF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Avicanna

Industry

Pharmaceuticals

Employees

55

CEO

Aras Azadian, MBA

Headquarters

Toronto, ON M5G 1V2, CA

AVCNF Financials

Key Financial Metrics (TTM)

Gross Margin

52%

Operating Margin

-13%

Net Income Margin

-7%

Return on Equity

-78%

Return on Capital

-26%

Return on Assets

-9%

Earnings Yield

-10.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.32M

Shares Outstanding

125.68M

Volume

33.38K

Short Interest

0.00%

Avg. Volume

32.63K

Financials (TTM)

Gross Profit

$12.90M

Operating Income

$4.68M

EBITDA

$2.43M

Operating Cash Flow

$2.55M

Capital Expenditure

$402.57K

Free Cash Flow

$2.95M

Cash & ST Invst.

$448.03K

Total Debt

$109.23K

Avicanna Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$6.40M

+2.0%

Gross Profit

$3.15M

-11.8%

Gross Margin

49.23%

N/A

Market Cap

$14.32M

N/A

Market Cap/Employee

$164.57K

N/A

Employees

87

N/A

Net Income

$1.38M

-75.9%

EBITDA

$1.18M

-129.2%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$333.76K

-42.7%

Accounts Receivable

$2.50M

-9.6%

Inventory

$4.56M

+16.4%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-8.87%

N/A

Return on Invested Capital

-25.65%

N/A

Free Cash Flow

$865.19K

-222.0%

Operating Cash Flow

$842.52K

-282.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CNTMFFluent Corp.
$0.04-10.86%
IZOZFIzotropic Corporation
$0.17+0.96%
VYYRFVoyageur Pharmaceuticals Ltd.
$0.10+0.00%
MEDIFMediPharm Labs Corp.
$0.05-3.11%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About AVCNF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.